Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 7/20 | 0.36 |
| ▸ | CNR1 | P21554 | 3/20 | 0.36 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10221309 | 0.83 | CNR2 (0.55) | CNR2CNR1 | |
| SCHEMBL10219899 | 0.82 | CNR2 (0.46) | CNR2CNR1 | |
| SCHEMBL14666110 | 0.71 | CNR2 (0.70) | CNR2CNR1 | |
| SCHEMBL10217823 | 0.70 | CNR2 (0.47) | CNR2CNR1 | |
| SCHEMBL10217365 | 0.69 | CNR2 (0.40) | CNR2CNR1 | |
| SCHEMBL10220123 | 0.67 | CNR2 (0.41) | CNR2CNR1 | |
| SCHEMBL12752887 | 0.66 | EGFR (0.51) | CNR2CNR1 | |
| SCHEMBL12566882 | 0.65 | CNR2 (0.39) | CNR2CNR1 | |
| SCHEMBL10217011 | 0.65 | CNR2 (0.80) | CNR2CNR1 | |
| SCHEMBL10221854 | 0.65 | CNR2 (0.80) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120010184-A1 | Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120010184-A1 | Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor | CNR2, CNR1, OPRL1 | CNR2 1/4885CNR1 2/4885HSP90AB1 1310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.